# IM Cannabis Corp. (IMCC)

Source page: https://stoqly.net/companies/imcc

- **Ticker:** IMCC (Nasdaq)
- **Sector:** Health Care / Medicinal Chemicals & Botanical Products
- **SEC CIK:** 0001792030
- **Latest annual report:** 20-F filed 2026-03-30 (https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/zk2634906.htm)
- **Data updated:** 2026-11-09

## Key figures

- **Last close:** $0.63 on 2026-11-09 (−1.80% on the day)
- **Revenue (FY2025):** $39.1M
- **Revenue growth:** −0.8%
- **Revenue growth, 5-year CAGR:** +27.0%
- **Gross margin:** 17.7%
- **Operating margin:** −21.2%
- **Net margin:** −20.7%
- **Free cash flow:** $3.4M
- **Free cash flow margin:** 8.6%
- **Return on invested capital:** −101.7%
- **Return on equity:** −1,760.5%
- **Net debt:** $9.2M
- **Piotroski F-score:** 4/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/imcc/figures.csv

| US$ millions | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 7 | 12 | 27 | 42 | 36 | 39 | 39 |
| Operating income | -8 | -6 | -18 | -24 | -9 | -7 | -8 |
| Net income | -5 | -21 | -14 | -145 | -7 | -8 | -8 |
| Diluted EPS (US$) | -0.17 | -1.42 | -5.34 | -124.35 | -3.30 | -3.29 | — |
| Operating cash flow | -4 | -6 | -27 | -10 | -6 | -1 | 3 |
| Free cash flow | -6 | -8 | -31 | -11 | -6 | -1 | 3 |
| Cash | 11 | 7 | 11 | 2 | 1 | 1 | 2 |
| Debt and leases | — | 0 | 10 | 7 | 9 | 11 | 11 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.